Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Opening Keynote: The Future of Rare Disease Trials You Might Also Like Optimizing CRO and Vendor Selection - Examples from the Field Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Optimizing Rare Disease Clinical Trials with Real World Data Using NLP & AI Solutions for Trial Design Challenges in Rare Disease Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications
Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Opening Keynote: The Future of Rare Disease Trials You Might Also Like Optimizing CRO and Vendor Selection - Examples from the Field Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Optimizing Rare Disease Clinical Trials with Real World Data Using NLP & AI Solutions for Trial Design Challenges in Rare Disease Trials How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications
